RATIONALE: Omalizumab is an effective treatment for chronic urticaria. However, discontinuation often results in relapse. Questions remain regarding possible benefits of tapering omalizumab doses after achieving satisfactory response. METHODS: Electronic health records of 110 patients with encounter diagnosis ICD-10 code L50.x and documented omalizumab prescriptions at a tertiary medical center between 7/1/2014-6/30/2018 were reviewed. Sixty-eight patients were included in the final analysis after excluding 20 who did not start omalizumab and 22 with incomplete records. RESULTS: At time of review, urticaria was well-controlled or in remission in forty-four (65% [44/68] RATIONALE: A subset of Atopic Dermatitis (AD) patients are susceptible to cutaneous viral infections, including eczema herpeticum (ADEH+). ADEH+ is associated with increased Staphylococcus aureus colonization and the skin microbiome may alter viral immune responses. The major objective of the current study was to compare the skin microbiome and virome of ADEH+, ADEH-, and nonatopic (NA) participants. METHODS: Skin swabs were collected from 40 subjects (15 ADEH+, 12 ADEH-, and 13 NA). For AD patients, swabs were collected from lesional and nonlesional skin. 67 shotgun metagenomic libraries were generated to investigate the microbiome and virome profile. RESULTS: Lesional skin from ADEH+ showed significant microbial diversity reduction compared to lesional skin from ADEH-(p<0.05). Similar results were observed when nonlesional skin from ADEH+ and ADEH-was compared to NA skin. Decreased diversity was associated with increased relative abundance of S. aureus on lesional skin of ADEH+ compared to ADEH-subjects. ADEH+ subjects carried an increased viral load on lesional and nonlesional skin. While herpes simplex virus (HSV) showed similar relative abundance in all groups, human papillomavirus (HPV) and bacteriophages were significantly increased in lesional and nonlesional skin of ADEH+ (p<0.01). CONCLUSIONS: ADEH+ subjects showed an increased relative abundance of pathogenic bacteria, such as S. aureus, and viruses and a reduction of commensal bacteria. Increased HPV load was previously associated with warts, another viral complication of AD. This study indicates that ADEH+ is associated with other forms of microbial infection beyond HSVand provides new mechanistic insight into viral skin infections in AD. 
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Deciphering the microbiome and virome composition of patients with Atopic Dermatitis and Eczema Herpeticum (ADEH+) The major objective of the current study was to compare the skin microbiome and virome of ADEH+, ADEH-, and nonatopic (NA) participants. METHODS: Skin swabs were collected from 40 subjects (15 ADEH+, 12 ADEH-, and 13 NA). For AD patients, swabs were collected from lesional and nonlesional skin. 67 shotgun metagenomic libraries were generated to investigate the microbiome and virome profile. RESULTS: Lesional skin from ADEH+ showed significant microbial diversity reduction compared to lesional skin from ADEH-(p<0.05). Similar results were observed when nonlesional skin from ADEH+ and ADEH-was compared to NA skin. Decreased diversity was associated with increased relative abundance of S. aureus on lesional skin of ADEH+ compared to ADEH-subjects. ADEH+ subjects carried an increased viral load on lesional and nonlesional skin. While herpes simplex virus (HSV) showed similar relative abundance in all groups, human papillomavirus (HPV) and bacteriophages were significantly increased in lesional and nonlesional skin of ADEH+ (p<0.01). CONCLUSIONS: ADEH+ subjects showed an increased relative abundance of pathogenic bacteria, such as S. aureus, and viruses and a reduction of commensal bacteria. Increased HPV load was previously associated with warts, another viral complication of AD. This study indicates that ADEH+ is associated with other forms of microbial infection beyond HSVand provides new mechanistic insight into viral skin infections in AD. -differentiated primary human keratinocytes were grown with and without IL-17A or IL-4/IL-13 and lipids were analyzed by targeted liquid chromatography tandem mass spectrometry (LC-MS/ MS). Stable isotope pulse-labeling was employed to define changes in sphingolipid metabolism in IL-17A, IL-4/IL-13 vs. sham-treated keratinocytes. Skin barrier function and lipid profiles were determined in skin tape strips of mice induced to express IL-17A after treatment with topical imiquimod application. RESULTS: In contrast to IL-4/IL-13, IL-17A significantly increased ceramide production in keratinocytes. This effect of IL-17A was explained by the upregulation of serine palmitoyltransferase subunit-1 (SPT1) expression and SPT activity, resulting in increased sphingolipid biosynthesis as shown by U-[ 13 C,
15 N]-serine pulse-labeling experiments. IL-4/ IL-13 inhibited SPT1 expression and activity and suppressed de novo sphingolipid biosynthesis. The effects of IL-17A were inhibited in keratinocytes transfected with TRAF3IP2 siRNA, an adaptor protein associated with IL-17A receptor heterodimer. In mice, imiquimod treatment induced psoriasis and upregulated skin levels of IL-17A. In addition, imiquimodtreated mice had a substantial increase in skin transepidermal water loss, disproportionate upregulation in non-hydroxy fatty acid sphingosine (NS)-ceramides and reduced EOS-ceramide levels as compared to vaseline-treated mice. CONCLUSIONS: IL-17A increased the expression and activity of SPT1 and significantly enhanced ceramide production by keratinocytes. IL-4/IL-13, however, inhibited SPT1 expression and activity and suppressed de novo ceramide biosynthesis. IL-17A-induced increase in keratinocyte ceramide production was abolished in keratinocytes with inhibited TRAF3IP2 expression.
